Document ID: chunk:federal_register_of_legislation:F2025C00126:schedule:1:p15
Version: federal_register_of_legislation:F2025C00126
Segment Type: schedule
Provision Reference: sch 1 (pt 15/23)
Character Range: 98199–105604

(a) between 1 July 2023 and 31 December 2023—4 months stock by reference to usual demand
                                                                                                                                                                                                                                                                                           (b) after 31 December 2023—5 months stock by reference to usual demand
Perindopril                                                                         Tablet containing perindopril erbumine 4 mg                                                                            Oral                        Indosyl Mono 4                                      (a) between 1 July 2023 and 31 December 2023—4.5 months stock by reference to usual demand
                                                                                                                                                                                                                                                                                           (b) after 31 December 2023—5.5 months stock by reference to usual demand
Perindopril with indapamide                                                         Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg                                        Oral                        Indosyl Combi 4/1.25                                (a) between 1 July 2023 and 31 December 2023—4 months stock by reference to usual demand
                                                                                                                                                                                                                                                                                           (b) after 31 December 2023—5 months stock by reference to usual demand
Perindopril with indapamide                                                         Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg                                        Oral                        Perindo Combi 4/1.25                                (a) between 1 July 2023 and 31 December 2023—2 months stock by reference to usual demand
                                                                                                                                                                                                                                                                                           (b) after 31 December 2023—2.5 months stock by reference to usual demand
Permethrin                                                                          Cream 50 mg per g, 30 g                                                                                                Application                 Lyclear                                             6 months stock by reference to usual PBS demand
Pimecrolimus                                                                        Cream 10 mg per g, 15 g                                                                                                Application                 Elidel                                              6 months stock by reference to usual PBS demand
Pioglitazone                                                                        Tablet 15 mg (as hydrochloride)                                                                                        Oral                        APOTEX-Pioglitazone                                 4 months stock by reference to usual demand of both APOTEX-Pioglitazone and ARX-PIOGLITAZONE added together
Pioglitazone                                                                        Tablet 15 mg (as hydrochloride)                                                                                        Oral                        ARX-PIOGLITAZONE                                    4 months stock by reference to usual demand of both APOTEX-Pioglitazone and ARX-PIOGLITAZONE added together
Pioglitazone                                                                        Tablet 30 mg (as hydrochloride)                                                                                        Oral                        APOTEX-Pioglitazone                                 4 months stock by reference to usual demand of both APOTEX-Pioglitazone and ARX-PIOGLITAZONE added together
Pioglitazone                                                                        Tablet 30 mg (as hydrochloride)                                                                                        Oral                        ARX-PIOGLITAZONE                                    4 months stock by reference to usual demand of both APOTEX-Pioglitazone and ARX-PIOGLITAZONE added together
Pioglitazone                                                                        Tablet 45 mg (as hydrochloride)                                                                                        Oral                        APOTEX-Pioglitazone                                 4 months stock by reference to usual demand of both APOTEX-Pioglitazone and ARX-PIOGLITAZONE added together
Pioglitazone                                                                        Tablet 45 mg (as hydrochloride)                                                                                        Oral                        ARX-PIOGLITAZONE                                    4 months stock by reference to usual demand of both APOTEX-Pioglitazone and ARX-PIOGLITAZONE added together
Piroxicam                                                                           Dispersible tablet 20 mg                                                                                               Oral                        Feldene-D                                           between 1 February 2025 and 31 March 2025—0 months stock by reference to usual demand
Polyethylene glycol 400 with propylene glycol                                       Eye drops 4 mg-3 mg per mL, 15 mL                                                                                      Application to the Eye      Optix                                               between 1 February 2025 and 30 April 2025—0 months stock by reference to usual demand
Pregabalin                                                                          Capsule 150 mg                                                                                                         Oral                        Cipla Pregabalin                                    between 1 October 2024 and 28 February 2025—0 months stock by reference to usual demand
Probenecid                                                                          Tablet 500 mg                                                                                                          Oral                        Pro‑Cid                                             6 months stock by reference to usual PBS demand
Prochlorperazine                                                                    Injection containing prochlorperazine mesilate 12.5 mg in 1 mL                                                         Injection                   Stemetil                                            6 months stock by reference to usual PBS demand